Protagonist Therapeutics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Brisbane Australia (2001)

Organization Overview

First Clinical Trial
2016
NCT02895100
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Protagonist Therapeutics | Protagonist Therapeutics, Inc.